These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12271597)

  • 1. [Meteospazmil and its place in treating patients with irritable bowel syndrome].
    Minushkin ON
    Eksp Klin Gastroenterol; 2002; (1):94-7. PubMed ID: 12271597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Meteospazmil for correction of motor disorders in functional colon diseases].
    Agafonova NA; Iakovenko EP; Ivanov AN; Prianishnikova AS; Iakovenko AV
    Eksp Klin Gastroenterol; 2009; (4):101-6. PubMed ID: 19961001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of Debridat in treating the irritable bowel syndrome].
    Parfenov AI
    Voen Med Zh; 1996 May; 317(5):37-8. PubMed ID: 8754091
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on irritable bowel syndrome.
    Bergmann KA
    Postgrad Med J; 2003 Dec; 79(938):715. PubMed ID: 14707260
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary thoughts on the treatment of irritable bowel syndrome.
    Giaquinta D
    Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
    [No Abstract]   [Full Text] [Related]  

  • 6. [New drug for irritable bowel syndrome].
    Hennemann A
    Med Monatsschr Pharm; 2001 Apr; 24(4):106-8. PubMed ID: 11338633
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of irritable bowel syndrome with dicetelium and spasmomen].
    Nedogoda SV; Parshev VV
    Klin Med (Mosk); 2000; 78(10):42-6. PubMed ID: 11220900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome.
    Tudor GJ
    Br J Clin Pract; 1986 Jul; 40(7):276-8. PubMed ID: 3527247
    [No Abstract]   [Full Text] [Related]  

  • 9. Alosetron for irritable bowel syndrome. Senior vice president of GlaxoSmithKline responds.
    Palmer JB
    BMJ; 2003 Jan; 326(7379):51. PubMed ID: 12511473
    [No Abstract]   [Full Text] [Related]  

  • 10. New drugs to treat irritable bowel syndrome being tested.
    Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

  • 12. [Irritable bowel syndrome: current views on its pathogenesis, diagnosis and treatment].
    Sheptulin AA
    Klin Med (Mosk); 1997; 75(9):26-9. PubMed ID: 9432536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diets in irritable bowel syndrome--what do they really achieve? Please no culinary sadism!].
    Stiefelhagen P
    MMW Fortschr Med; 2001 Nov; 143(46):18. PubMed ID: 11759593
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional intestinal disorders and quality of life].
    Chassany O; Bergmann JF
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C54-62. PubMed ID: 11787380
    [No Abstract]   [Full Text] [Related]  

  • 15. Glaxo Wellcome withdraws irritable bowel syndrome medication.
    FDA Consum; 2001; 35(1):3. PubMed ID: 11930921
    [No Abstract]   [Full Text] [Related]  

  • 16. Irritable bowel syndrome: new approaches to its pharmacological management.
    Tougas G
    Can J Gastroenterol; 2001 Oct; 15 Suppl B():12B-13B. PubMed ID: 11694909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alosetron for irritable bowel syndrome.
    Lièvre M
    BMJ; 2002 Sep; 325(7364):555-6. PubMed ID: 12228116
    [No Abstract]   [Full Text] [Related]  

  • 18. Irritable bowel syndrome. A poorly understood disorder.
    Lewis C
    FDA Consum; 2001; 35(4):30-6. PubMed ID: 11692885
    [No Abstract]   [Full Text] [Related]  

  • 19. Alosetron for irritable bowel syndrome. Risks of using alosetron are still unknown.
    Palmer RH
    BMJ; 2003 Jan; 326(7379):51. PubMed ID: 12518769
    [No Abstract]   [Full Text] [Related]  

  • 20. New drugs in the management of the irritable bowel syndrome.
    Farthing MJ
    Drugs; 1998 Jul; 56(1):11-21. PubMed ID: 9664195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.